Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Hematology/Oncology Clinics of North America|February 1, 1994
Clinical relevance of breast cancer biologyA M Oza, I F TannockGastrointestinal Endoscopy Clinics of North America|May 16, 1998
Radiation and chemotherapy in the management of malignant esophageal stricturesJ D Brierley, A M OzaEpidemiologic Reviews|January 1, 1993
Mammographic parenchymal patterns: a marker of breast cancer riskA M Oza, N F BoydAnti-Cancer Drugs|January 16, 1999
Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and costA Patnaik, C Doyle, A M OzaBailliere'S Clinical Haematology|January 1, 1991
Chemotherapy of Hodgkin's diseaseA M Oza, A Z Rohatiner, T A ListerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancerC Doyle, M Crump, M Pintilie, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 25, 2002
Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot studyA J Davis, W Chapman, D W Hedley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Resource implications of palliative chemotherapy for ovarian cancerC Doyle, M Stockler, M Pintilie, et al.Cancer Research|October 1, 1994
A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's diseaseA M Oza, S Tonks, J Lim, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 2, 2007
Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic reviewH W Hirte, J E Strychowsky, T Oliver, et al.Pageof 5